Zyryanov S.K. - list of publications

THE USE OF NEW DOSAGE FORMS OF ANTIBIOTICS AS A WAY TO IMPROVE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY

Article

Zyryanov S.K., Baibulatova E.A.

Antibiotiki i Khimioterapiya. Vol. 64. 2019. P. 81-91

ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS

Article

Rodoman G.V., Zyryanov S.K., Romashov O.M., Ivzhits M.A., Putsman G.A., Ionidi P.V., Kosenko O.A., Chenkurov M.S.

Хирург. 2019. P. 45-59

MURAMYLDIPEPTIDE-BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE [СОЕДИНЕНИЯ НА ОСНОВЕ МУРАМИЛПЕПТИДОВ В СОВРЕМЕННОЙ МЕДИЦИНЕ: ФОКУС НА ГЛЮКОЗАМИНИЛМУРАМИЛДИПЕПТИД]

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Vol. 91. 2019. P. 122-128

MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE

Article

Kuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K.

Antibiotiki i Khimioterapiya. Vol. 64. 2019. P. 48-53

MODERN APPROACHES TO IMPROVING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN PERINATOLOGY: LOCAL EXPERIENCE

Article

Kazanova A.M., Zyryanov S.K., Ivzhits M.A., Kruglov A.N., Kutsaya K.O., Chenkurov M.S.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 66-74

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Vol. 91. 2019. P. 122-127

CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND

Article

Bobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.

Russian Open Medical Journal. Russian Open Medical Journal. Vol. 8. 2019.

BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS

Article

Diakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.

Медицинские технологии. Оценка и выбор. Фонд развития социальной политики и здравоохранения Гелиос. 2019. P. 71-80

THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER

Article

Bobrova Olga, Schnider Natalya, Zyryanov Sergey, Dmitrenko Diana, Zobova Svetlana, Zukov Ruslan

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 53-59

ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS

Article

Zatolochina K.E., Ushkalova E.A., Zyryanov S.K., Polivanov V.A.

Хирург. 2019. P. 69-73

CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH

Article

Tolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.

Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. Vol. 11. 2019. P. 48-60

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 4-14

PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS

Article

Zyryanov S.K., Dyakov I.N., Khachatryan N.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 55-69

DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS

Article

Kuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K., Glagolev S.V.

Вестник Росздравнадзора. Федеральное государственное бюджетное учреждение Информационно-методический центр по экспертизе, учету и анализу обращения средств медицинского применения Росздравнадзора. 2019. P. 59-62

THERAPEUTIC DRUG MONITORING OF LEVETIRACETAM IN NEWBORNS

Article

Bondareva I.B., Ivzhits M.A., Zyryanov S.K., Chenkurov M.S.

Анналы клинической и экспериментальной неврологии. Закрытое акционерное общество "РКИ Соверо пресс". Vol. 13. 2019. P. 65-76

ФАРМАКОНАДЗОР

Monograph

Kolbin A.S., Kolbin A.S., Zyryanov S.K., Zyryanov S.K., Belousov D.Yu., Belousov D.Yu., Логиновская О.А., Матвеев А.В., Romanov B.K., Глаголев С.В., Plavinsky S.L., Burbello A.T., Zagorodnikova K.A., Karpenko L.I.

ОКИ: Буки-Веди. 2019. 248 p.

MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA

Article

Zyryanov Sergey, Dyakov Ilya, Karpov Oleg

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 4-12

ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Article

Зырянов С.К., Белевский А.С., Дьяков И.Н.

Астма и аллергия. 2019. P. 28-37

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

Article

Ushkalova E.A., Zyryanov S.K., Zalolochina K.E.

Медицинский совет. ООО «ГРУППА РЕМЕДИУМ». 2019. P. 110-120

POTENTIALLY PRESCRIBING OMISSIONS IN ELDERLY PATIENTS: PREVALENCE, RISK FACTORS AND IDENTIFICATION

Article

Al-Ragawi Ali, Zyryanov Sergey

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2019. 146 p.

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

Article

Al-Rajavi A., Zyryanov S.K., Ushkalova E.A., Butranova O.I., Pereverzev A.P.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 57-65

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 23-32

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH CARIPRAZINE IN SCHIZOPHRENIA

Article

Dyakov I.N., Zyryanov S.K.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Vol. 119. 2019. P. 66-77

PARAPROCTITIS: ETIOLOGY AND CURRENT FEATURES OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS

Article

Rodoman G.V., Zyryanov S.K., Ivzhits M.A., Romashov O.M., Alexandrov M.I., Putsman G.A., Ionidi P.V.

Хирург. 2019. P. 40-49

GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE [ПРОБЛЕМЫ ГЕРИАТРИИ В КАРДИОЛОГИЧЕСКОЙ ПРАКТИКЕ]

Article

Tkacheva O.N., Belenkov Yu.N., Karpov Yu.A., Zyryanov S.K.

Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 54-63

Зырянов С.К.

List of records

THE USE OF NEW DOSAGE FORMS OF ANTIBIOTICS AS A WAY TO IMPROVE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY

ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS

MURAMYLDIPEPTIDE-BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE [СОЕДИНЕНИЯ НА ОСНОВЕ МУРАМИЛПЕПТИДОВ В СОВРЕМЕННОЙ МЕДИЦИНЕ: ФОКУС НА ГЛЮКОЗАМИНИЛМУРАМИЛДИПЕПТИД]

MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE

MODERN APPROACHES TO IMPROVING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN PERINATOLOGY: LOCAL EXPERIENCE

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND

BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS

THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER

ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS

CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS

DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS

THERAPEUTIC DRUG MONITORING OF LEVETIRACETAM IN NEWBORNS

ФАРМАКОНАДЗОР

MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

POTENTIALLY PRESCRIBING OMISSIONS IN ELDERLY PATIENTS: PREVALENCE, RISK FACTORS AND IDENTIFICATION

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH CARIPRAZINE IN SCHIZOPHRENIA

PARAPROCTITIS: ETIOLOGY AND CURRENT FEATURES OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS

GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE [ПРОБЛЕМЫ ГЕРИАТРИИ В КАРДИОЛОГИЧЕСКОЙ ПРАКТИКЕ]

Other authors

Velibekov M.C.

Gorbatenko R.G.